Compugen (CGEN) Reports Q1 Loss of $0.17/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Compugen (CGEN) Reports Q1 Loss of $0.17/Share

Compugen Reports First Quarter 2017 Results

May 9, 2017 7:13 AM EDT

HOLON, Israel, May 9, 2017 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery company, today reported financial results for the first quarter ended March 31, 2017.

Anat Cohen-Dayag, Ph.D., CEO and President of Compugen, stated, "During this quarter we saw continuing scientific and therapeutic development advancements as well as business development progress in our four focus program areas:

COM701, an antibody drug candidate against PVRIG, a novel immune checkpoint target, with the potential to serve for both mono-... More